ARCT - Arcturus Therapeutics Is A Worthwhile Bet As The Next Blockbuster COVID-19 Vaccine Play
- ARCT peaked and then slumped in recent weeks as investors lost interest in its coronavirus vaccine.
- Promising platform and advantages suggests this is a worthwhile holding.
- Upside price target (of a double) discussed but depends on vaccine approval.
For further details see:
Arcturus Therapeutics Is A Worthwhile Bet As The Next Blockbuster COVID-19 Vaccine Play